查询
最新公告

《儿童和青少年精神药物临床手册》第五版

2023 | ISBN: 0889376255 | English | 498 pages | True PDF | 4 MB

Quick and comprehensive information on psychotropic drugs for children and adolescents.

– Accurate and up-to-date – Specific to children and adolescents – Charts and tables help decision-making – Icons and full color The Clinical Handbook of Psychotropic Drugs for Children and Adolescents has become a standard reference and working tool for psychiatrists, pediatricians, psychologists, physicians, pharmacists, nurses, and other mental health professionals.

• Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options • Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, nursing implications, and much more – all you need to know for each class of drug • Potential interactions and side effects summarized in comparison charts • With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek • Clearly written patient and caregiver information sheets for download as printable PDF files This book is a must for all mental health professionals working with children and adolescents who need an up-to-date, easy-to use, comprehensive summary of all the most relevant information about psychotropic drugs.

New in this edition

• New chapters on Prescribing Safely and Ethically to Children and Adolescents, Pharmacogenetic Information for Common Psychotropic Drugs, and Aggression Management in Children and Adolescents • Neuroscience-based nomenclature added to Product Availability tables • Antipsychotic-Induced Extrapyramidal Side Effect (EPSE) completely revised plus new section on monitoring scales for EPSE • Anxiolytics section on buspirone and benzodiazepine comparison table revised • Mood Stabilizers chapter extensively revised • Natural Health Products comprehensively revised • New Unapproved Treatments revised, including preliminary evidence for cannabidiol and folinic acid for autism spectrum disorder and ketamine for mood disorder • New agents include: deutetrabenazine, ethopropazine, lemborexant, lumateperone, orphenadrine, tetrabenazine, valbenazine, viloxazine • New formulations and trade names include: Austedo, Caplyta, Dayvigo, Drizalma Sprinkle, Elepsia XR, Eprontia, Evekeo ODT, Gocovri, Hetlioz LQ, Ingrezza, Invega Hafyera, Jornay PM, Loreev XR, Lybalvi, Osmolex ER, Oxtellar XR, Parsitan, Perseris, Qelbree, Qudexy XR, Secuado, Spritam, Tyrvaya, Valtoco


快速而详尽的儿童和青少年心理药物信息。 – 准确且最新 – 专为儿童和青少年设计 – 图表和表格有助于决策 – 图标和全彩呈现 《儿童和青少年心理药物临床手册》已成为精神科医生、儿科医生、心理学家、内科医生、药师、护士及其他心理健康专业人士的标准参考工具和工作用书。 • 包含独特且易于阅读的比较图表和表格(剂量、副作用、药代动力学、相互作用等),提供治疗选择的快速概览 • 简洁明了地列出所有类别的药物信息:处方和非处方适用情况、副作用、相互作用、药效动力学、护理意义及其他所有你需要知道的信息 • 汇总在比较图表中的潜在相互作用和副作用 • 在图标和全彩呈现下,让你一目了然地找到你所需的全部信息 • 提供可下载的打印PDF文件患者与照护者信息手册 这本书对需要了解有关心理药物全面总结的所有儿童和青少年心理健康专业人士来说都是必备之选。 新版本新增内容: • 新增关于安全合理用药及伦理、常见精神药物遗传学信息以及儿童和青少年行为管理章节 • 在产品可用性表格中添加基于神经科学的术语 • 抗精神病药诱导外周神经系统副作用(EPSE)完全修订并新增EPSE监测量表部分 • 口服安非他明与苯二氮卓类比较图表更新,焦虑药物中的布西泮和苯二氮卓类比较图表重新设计 • 情绪稳定剂章节全面重修 • 自然健康产品广泛重修 • 新治疗修订,包括用于自闭症谱系障碍的初步证据提示及用于情绪紊乱的卡纳芬酸;初步证据提示提示提示提示 • 新增药物包含:去特布环醇、乙氧酚嗪、莱莫索坦、拉马肽酮、奥苯达罗、托克宾泽尔、瓦班唑、维洛昔康 • 新剂型和商品名包括:艾佐多、卡普利塔、日沃吉、狄里扎玛散、易普西莉亚XR、埃平蒂卡、伊刻科瓦、戈柯维利、赫特利亚兹LQ、恩格齐、因杰拉海菲耶、乔纳斯PM、洛瑞维尔、利巴薇、奥斯迈乐ER、奥斯特拉尔克斯R、帕士坦、普塞利思、奎布里、库德西亚克XR、塞库多、斯匹坦、蒂维萨、瓦特罗尔 新的制剂和商品名
Download from free file storage


本站不对文件进行储存,仅提供文件链接,请自行下载,本站不对文件内容负责,请自行判断文件是否安全,如发现文件有侵权行为,请联系管理员删除。